KRAS and rectal cancer: Distinct molecular pathways are preferentially involved in the adenoma-carcinoma sequence in the proximal and the distal colon with TP53 and KRAS mutations being favored in rectal cancer, whereas mismatch repair defects are more common in proximal colon tumors [7].